Virtus ETF Advisers LLC Ionis Pharmaceuticals Inc Transaction History

Virtus ETF Advisers LLC

$206 Million
Q3 2024

A detailed history of Virtus ETF Advisers LLC transactions in Ionis Pharmaceuticals Inc stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 8,009 shares of IONS stock, worth $292,568. This represents 0.16% of its overall portfolio holdings.

Number of Shares

8,009

Previous 8,009 -0.0%

Holding current value

$292,568

Previous $381,000 16.01%

% of portfolio

0.16%

Previous 0.19%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$36.45 - $47.7 $13,158 - $17,219	361 Added 4.72%	8,009 $381,000
Q1 2024 May 15, 2024	BUY	$42.03 - $53.55 $46,233 - $58,905	1,100 Added 16.8%	7,648 $331,000
Q4 2023 Feb 15, 2024	SELL	$43.39 - $51.63 $39,441 - $46,931	-909 Reduced 12.19%	6,548 $331,000
Q3 2023 Nov 07, 2023	SELL	$38.5 - $47.13 $36,998 - $45,291	-961 Reduced 11.42%	7,457 $338,000
Q2 2023 Aug 14, 2023	BUY	$34.73 - $43.33 $12,989 - $16,205	374 Added 4.65%	8,418 $345,000
Q1 2023 May 15, 2023	BUY	$33.58 - $41.2 $4,835 - $5,932	144 Added 1.82%	8,044 $287,000
Q4 2022 Feb 14, 2023	BUY	$37.12 - $46.52 $32,331 - $40,518	871 Added 12.39%	7,900 $298,000
Q3 2022 Nov 14, 2022	BUY	$36.54 - $48.66 $3,800 - $5,060	104 Added 1.5%	7,029 $311,000
Q2 2022 Aug 12, 2022	SELL	$31.71 - $43.0 $170,314 - $230,953	-5,371 Reduced 43.68%	6,925 $256,000
Q4 2021 Feb 14, 2022	BUY	$25.61 - $35.1 $4,968 - $6,809	194 Added 1.6%	12,296 $374,000
Q3 2021 Nov 15, 2021	SELL	$33.54 - $40.55 $37,229 - $45,010	-1,110 Reduced 8.4%	12,102 $406,000
Q2 2021 Aug 10, 2021	BUY	$34.54 - $47.25 $4,421 - $6,048	128 Added 0.98%	13,212 $527,000
Q1 2021 May 17, 2021	BUY	$42.51 - $63.78 $15,261 - $22,897	359 Added 2.82%	13,084 $588,000
Q4 2020 Feb 12, 2021	BUY	$45.3 - $60.27 $122,853 - $163,452	2,712 Added 27.08%	12,725 $719,000
Q3 2020 Nov 13, 2020	BUY	$47.45 - $62.95 $40,000 - $53,066	843 Added 9.19%	10,013 $475,000
Q2 2020 Aug 05, 2020	SELL	$46.85 - $61.05 $7,449 - $9,706	-159 Reduced 1.7%	9,170 $541,000
Q1 2020 May 14, 2020	SELL	$41.6 - $63.4 $32,739 - $49,895	-787 Reduced 7.78%	9,329 $441,000
Q4 2019 Feb 13, 2020	SELL	$53.85 - $65.27 $56,004 - $67,880	-1,040 Reduced 9.32%	10,116 $611,000
Q3 2019 Nov 12, 2019	SELL	$59.06 - $72.15 $111,091 - $135,714	-1,881 Reduced 14.43%	11,156 $668,000
Q2 2019 Aug 13, 2019	BUY	$62.09 - $86.14 $809,467 - $1.12 Million	13,037 New	13,037 $838,000
Q1 2019 May 14, 2019	SELL	$52.92 - $81.17 $601,647 - $922,821	-11,369 Closed	0 $0
Q4 2018 Feb 05, 2019	SELL	$43.37 - $59.54 $223,919 - $307,405	-5,163 Reduced 31.23%	11,369 $615,000
Q3 2018 Nov 14, 2018	BUY	$42.88 - $53.7 $47,768 - $59,821	1,114 Added 7.23%	16,532 $853,000
Q2 2018 Aug 10, 2018	SELL	$40.53 - $50.7 $87,706 - $109,714	-2,164 Reduced 12.31%	15,418 $642,000
Q1 2018 May 14, 2018	SELL	$44.08 - $55.05 $45,314 - $56,591	-1,028 Reduced 5.52%	17,582 $775,000
Q4 2017 Feb 14, 2018	SELL	$50.3 - $64.39 $88,779 - $113,648	-1,765 Reduced 8.66%	18,610 $936,000
Q2 2017 Aug 14, 2017	BUY	N/A	20,375	20,375 $1.04 Million

Others Institutions Holding IONS

# of Institutions

402

Shares Held

136M

Call Options Held

862K

Put Options Held

582K

View Full List

About IONIS PHARMACEUTICALS INC

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.19B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

More about IONS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Ionis Pharmaceuticals Inc Transaction History